Resource use and costs · general population
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Any AMD · general population
Beta‐carotene showed no clear difference in any AMD compared with placebo (high certainty).
1 finding from 1 review
Progression to late AMD (neovascular AMD, geographic atrophy or both) · general population
Beta‐carotene showed no clear difference in late AMD (either neovascular AMD or geographic atrophy or both) compared with placebo (moderate certainty).
1 finding from 1 review
Recurrent VTE · patients with symptomatic VTE requiring long term treatment (3 months) for symptomatic VTE
LMWH showed no clear difference in incidence of recurrent VTE (treatment duration 3 months) compared with VKA (moderate certainty).
1 finding from 1 review
Major bleeding · patients with symptomatic VTE requiring long term treatment (3 months) for symptomatic VTE
LMWH may leads to lower incidence of major bleeding (treatment duration 3 months) compared with VKA (low certainty).
1 finding from 1 review
Mortality (treatment duration 3 months) · patients with symptomatic VTE requiring long term treatment (3 months) for symptomatic VTE
LMWH showed no clear difference in mortality (treatment duration 3 months) compared with VKA (moderate certainty).
1 finding from 1 review
Intervention not reported
HIV infection status of the child · HIV‐positive women during pregnancy and immediate postpartum period
The intervention showed no clear difference in HIV infection status of the child (moderate certainty).
1 finding from 1 review
Intervention not reported
Mean birthweight · HIV‐positive women during pregnancy and immediate postpartum period
The intervention showed no clear difference in mean birthweight (low certainty).
1 finding from 1 review
Intervention not reported
Low birthweight · HIV‐positive women during pregnancy and immediate postpartum period
The intervention probably leads to lower low birthweight (moderate certainty).
1 finding from 1 review
Intervention not reported
Child death by two years of age · HIV‐positive women during pregnancy and immediate postpartum period
The intervention showed no clear difference in child death by two years of age (low certainty).
1 finding from 1 review
Intervention not reported
Preterm delivery · HIV‐positive women during pregnancy and immediate postpartum period
It is very uncertain whether the intervention changes preterm delivery (very low certainty).
1 finding from 1 review
Intervention not reported
Stillbirth · HIV‐positive women during pregnancy and immediate postpartum period
It is very uncertain whether the intervention changes stillbirth (very low certainty).
1 finding from 1 review
Intervention not reported
Maternal death · HIV‐positive women during pregnancy and immediate postpartum period
It is very uncertain whether the intervention changes maternal death (very low certainty).
1 finding from 1 review
Intervention not reported
All‐cause mortality: longest · infants 1 to 6 months of age
The intervention showed no clear difference in all‐cause mortality: longest (moderate certainty).
1 finding from 1 review
Intervention not reported
Morbidity: diarrhoea: point prevalence · infants 1 to 6 months of age
The intervention showed no clear difference in morbidity: diarrhoea: point prevalence (moderate certainty).
1 finding from 1 review
Intervention not reported
Adverse effects: bulging fontanelle within 48 to 72 hours · infants 1 to 6 months of age
The intervention leads to higher adverse effects: bulging fontanelle within 48 to 72 hours (high certainty).
1 finding from 1 review
Intervention not reported
Adverse effects: vomiting 48 to 72 hours · infants 1 to 6 months of age
The intervention showed no clear difference in adverse effects: vomiting 48 to 72 hours (low certainty).
1 finding from 1 review
Intervention not reported
Adverse effects: diarrhoea 48 to 72 hours · infants 1 to 6 months of age
The intervention showed no clear difference in adverse effects: diarrhoea 48 to 72 hours (low certainty).
1 finding from 1 review
Intervention not reported
Adverse effects: fever 48 to 72 hours · infants 1 to 6 months of age
The intervention showed no clear difference in adverse effects: fever 48 to 72 hours (low certainty).
1 finding from 1 review
Eclampsia · pregnant women, either during the prenatal period or during labour.
1 finding from 1 review